Dissemination of antibiotic resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant S aureus strains isolated from hospital effluents

Published:September 29, 2015DOI:


      • Both methicillin-resistant Staphylococcus aureus and vancomycin-resistant S aureus strains were identified from hospital effluents.
      • Approximately 15% isolates were vancomycin resistant and all were methicillin resistant.
      • The vancomycin-resistant Staphylococcus aureus strains developed a VanR/VanS-regulated 2-component system of VanA-type resistance in their genome.
      • Vancomycin-resistant Staphylococcus aureus strains may have a possibility to develop resistance against aminoglycosides antibiotics in the near future.
      • Proper treatment of hospital-associated discharge is vital to stop the cross talk between pathogenic and nonpathogenic bacteria.
      Vancomycin-resistant Staphylococcus aureus (VRSA) and methicillin-resistant S aureus (MRSA) strains were examined in hospital effluents. Most S aureus strains are resistant to methicillin (MRSA), followed by tetracycline. Approximately 15% of MRSA strains are also resistant to vancomycin (VRSA). All VRSA strains developed a VanR/VanS-regulated 2-component system of VanA-type resistance in their genome. Results indicate that there is a possibility of developing resistance to aminoglycosides by VRSA strains in the near future.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Stalder T.
        • Barraud O.
        • Jové T.
        • Casellas M.
        • Gaschet M.
        • Dagot C.
        • et al.
        Quantitative and qualitative impact of hospital effluent on dissemination of the integron pool.
        ISME J. 2014; 8: 768-777
        • Chiu L.H.
        • Chiu C.H.
        • Horn Y.M.
        • Chiou C.S.
        • Lee C.Y.
        • Yeh C.M.
        • et al.
        Characterization of 13 multi-drug resistant Salmonella serovars from different broiler chickens associated with those of human isolates.
        BMC Microbiol. 2010; 10: 86-96
        • Clinical and Laboratory Standard Institute
        Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI document M100–S20.
        Clinical and Laboratory Standard Institute, Wayne [PA]2010
        • Sarkar S.K.
        • Bhattacharyya A.
        • Mandal S.M.
        YnfA, a SMR family efflux pump is abundant in Escherichia coli isolates from urinary infection.
        Indian J Med Microbiol. 2015; 33: 139-142
        • Song J.H.
        • Hiramatsu K.
        • Suh J.Y.
        • Ko K.S.
        • Ito T.
        • Kapi M.
        • et al.
        • Asian Network for Surveillance of Resistant Pathogens Study Group
        Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin.
        Antimicrobial Agents Chemother. 2004; 48: 4926-4928
        • Courvalin P.
        Vancomycin-resistant gram-positive cocci.
        Clin Infect Dis. 2006; 42: S25-S34
        • Chambers H.F.
        Methicillin-resistant Staphylococcus aureus. Mechanisms of resistance and implications for treatment.
        Postgrad Med. 2001; 109: 43-50
        • Stein G.E.
        • Wells E.M.
        The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and softtissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
        Curr Med Res Opin. 2010; 26: 571-588